Compare GSK plc (GSK) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Public Storage — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Public Storage trades at $289.86 (market cap $53.35B). The key difference: GSK plc is the larger of the two by market cap, and Public Storage pays the higher dividend (4.2%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Public Storage for 130 Days on average.
| GSK | PSA | |
|---|---|---|
Market Cap | $91.88B | $53.35B |
Volume | 7,730,529 | 1,176,034 |
Sector | Health | Real Estate |
52-Week High | $61.18 | $330.47 |
52-Week Low | $43.24 | $258.44 |
Typical Hold Time | 93 Days | 130 Days |
Enterprise Value | $111.88B | $67.62B |
Dividend Yield | 3.9% | 4.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
Public Storage (PSA) trades at $285.52, up 1.25% with a bearish technical signal despite strong profitability metrics. The REIT maintains robust fundamentals with 41.8% net income margin and consistent earnings beats, though valuation ratios appear elevated. Recent developments include the completion of Public Storage Canada acquisition and a $400 million Canadian debt offering, signaling expansion efforts. Cash flow trends show operational stability with $3.19B from operations in 2025, though net cash flow remains negative due to significant investing activity.
The stock presents a mixed outlook with analyst consensus target of $328.33 suggesting 15% upside potential, yet technical indicators and some bearish sentiment create near-term uncertainty. Key risks include REIT sector sensitivity to interest rates and competitive pressures, while the 4.05% dividend yield provides income support. Institutional activity shows mixed positioning with recent large purchases offset by selective reductions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
